Search

Your search keyword '"López-Gómez C"' showing total 35 results

Search Constraints

Start Over You searched for: Author "López-Gómez C" Remove constraint Author: "López-Gómez C"
35 results on '"López-Gómez C"'

Search Results

1. RWD89 Economic Burden of Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring KRASG12C Mutation in Spain

Catalog

Books, media, physical & digital resources

8. ALTEA: A Software Tool for the Evaluation of New Biomarkers for Alzheimer's Disease by Means of Textures Analysis on Magnetic Resonance Images

9. Comparación de profundidades de Labranza Reducida y Siembra Directa con y sin humus de lombriz en el cultivo de la zanahoria.

14. Comment on: Report of terbinafine-resistant Trichophyton indotineae in a pregnant patient-A diagnostic and therapeutic challenge.

15. Mitochondrial Stress Links Environmental Triggers with Pro-Inflammatory Signaling in Crohn's Disease.

16. Role of Mitochondria in Inflammatory Bowel Diseases: A Systematic Review.

17. Membrane Vesicles of Toxigenic Clostridioides difficile Affect the Metabolism of Liver HepG2 Cells.

18. The Metagenomic Composition and Effects of Fecal-Microbe-Derived Extracellular Vesicles on Intestinal Permeability Depend on the Patient's Disease.

19. Pharmaceutical care at discharge for patients with feeding tubes.

20. 232nd ENMC international workshop: Recommendations for treatment of mitochondrial DNA maintenance disorders. 16 - 18 June 2017, Heemskerk, The Netherlands.

21. Morbid Obesity in Women Is Associated with an Altered Intestinal Expression of Genes Related to Cancer Risk and Immune, Defensive, and Antimicrobial Response.

22. Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

25. Oleic Acid Protects Against Insulin Resistance by Regulating the Genes Related to the PI3K Signaling Pathway.

26. Jejunal Insulin Signalling Is Increased in Morbidly Obese Subjects with High Insulin Resistance and Is Regulated by Insulin and Leptin.

27. An admission medication reconciliation programme carried out by pharmacists: impact on surgeons' prescriptions.

28. TRAIL and TRAIL receptors splice variants during long-term interferon β treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response.

29. Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response.

30. Candidate gene study of TRAIL and TRAIL receptors: association with response to interferon beta therapy in multiple sclerosis patients.

31. The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis.

32. Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.

33. TRAIL/TRAIL receptor system and susceptibility to multiple sclerosis.

34. [Opinion and Participation in the Regional Early Breast Cancer Detection Program in 2007 on the part of family physicians from a health district in the Autonomous Community of Madrid, Spain].

35. [Conjunctivitis caused by Branhamella].